Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
7.35
+0.10 (1.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Inogen Revenue
In the year 2025, Inogen had annual revenue of $348.67M with 3.86% growth. Inogen had revenue of $81.72M in the quarter ending December 31, 2025, with 2.05% growth.
Revenue (ttm)
$348.67M
Revenue Growth
+3.86%
P/S Ratio
0.58
Revenue / Employee
$463,039
Employees
753
Market Cap
200.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 348.67M | 12.96M | 3.86% |
| Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
| Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
| Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
| Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InfuSystem Holdings | 143.44M |
| Quanterix | 138.90M |
| Owlet | 105.71M |
| Sight Sciences | 77.36M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| 908 Devices | 56.20M |
| Apyx Medical | 52.84M |
INGN News
- 5 days ago - Inogen to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 14 days ago - Inogen Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 22 days ago - Inogen Announces the Appointment of Vafa Jamali to Board of Directors - Business Wire
- 4 weeks ago - Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 4 weeks ago - Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth - Business Wire
- 6 weeks ago - Inogen Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 7 weeks ago - Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum - Business Wire